1
ONS ONCC CHEMOTHERAPY
IMMUNOTHERAPY CERTIFICATION
Actual Exam 2026/2027 Complete Questions
and Verified Answers Graded A+ Pass
Guaranteed - A+ Graded
DOMAIN 1: FOUNDATIONS OF CANCER & TREATMENT (Questions 1-25)
Subdomain: Cancer Biology (Questions 1-10)
Question 1
A 52-year-old patient is diagnosed with breast cancer. The pathology report indicates the tumor is
estrogen receptor-positive (ER+), HER2-negative, and has a Ki-67 proliferation index of 15%.
The nurse understands that the Ki-67 index measures which cellular process?
A. Rate of apoptosis (programmed cell death)
B. Percentage of cells in the active phases of the cell cycle
C. Degree of tumor differentiation
D. Expression of tumor suppressor genes
Correct Answer: B
Rationale: The Ki-67 protein is present during all active phases of the cell cycle (G1, S, G2, and
mitosis) but absent in resting cells (G0). It serves as a marker of cellular proliferation. A Ki-67
index of 15% indicates that 15% of tumor cells are actively dividing, which helps determine
tumor aggressiveness and guides treatment decisions. Lower Ki-67 indices (<14%) generally
indicate less aggressive tumors with better prognosis, while higher indices (>30%) suggest more
aggressive disease requiring more intensive therapy.
Key Point: Ki-67 is a proliferation marker, not a marker of apoptosis, differentiation, or tumor
suppressor gene expression.
,2
Question 2
A patient asks the nurse to explain why combination chemotherapy is more effective than single-
agent therapy for most cancers. Which response best explains the scientific rationale?
A. "Multiple drugs reduce the likelihood of drug resistance developing"
B. "Combination therapy allows lower doses of each drug, reducing toxicity"
C. "Different drugs target cancer cells at various phases of the cell cycle"
D. "Combining drugs increases the total number of cancer cells killed"
Correct Answer: C
Rationale: The primary rationale for combination chemotherapy is that different agents have
varying mechanisms of action and cell cycle specificity. By combining drugs that target different
phases of the cell cycle (e.g., cell cycle-specific agents like antimetabolites for S-phase and cell
cycle-nonspecific agents like alkylating agents), the regimen can kill cancer cells regardless of
their position in the cell cycle. This approach also reduces the development of resistance (Goldie-
Coldman hypothesis) and allows for dose intensity without exceeding single-agent toxicity
limits.
Key Point: Cell cycle specificity is the fundamental principle underlying combination
chemotherapy regimens.
Question 3
Which genetic alteration is most characteristic of tumor suppressor genes in cancer
development?
A. Gain-of-function mutations that promote continuous cell signaling
B. Loss-of-function mutations that remove cell cycle checkpoints
C. Chromosomal translocations creating fusion proteins
D. Gene amplifications leading to protein overexpression
Correct Answer: B
Rationale: Tumor suppressor genes (e.g., TP53, RB1, BRCA1/2) function as "brakes" on cell
proliferation by regulating cell cycle checkpoints, promoting DNA repair, or inducing apoptosis.
Cancer development typically requires loss-of-function mutations in both alleles (Knudson's
"two-hit hypothesis"), removing these regulatory controls. In contrast, oncogenes involve gain-
of-function mutations, chromosomal translocations (e.g., BCR-ABL in CML), or gene
amplifications (e.g., HER2/neu in breast cancer).
Key Point: Tumor suppressor genes require inactivation (loss-of-function), while oncogenes
require activation (gain-of-function).
,3
Question 4
A patient with colon cancer is staged as T3N1M0 using the TNM system. The nurse understands
that the "N1" designation indicates:
A. Distant metastasis to regional lymph nodes
B. Metastasis to 1-3 regional lymph nodes
C. Tumor invasion through the muscularis propria
D. Presence of lymphovascular invasion
Correct Answer: B
Rationale: In the AJCC TNM staging system for colon cancer, the "N" category describes
regional lymph node involvement: N0 = no regional lymph node metastasis; N1 = metastasis in
1-3 regional lymph nodes (N1a = 1 node, N1b = 2-3 nodes, N1c = tumor deposits without
regional nodal metastasis); N2 = metastasis in 4 or more regional lymph nodes. T3 indicates
tumor invasion through the muscularis propria into pericolorectal tissues, and M0 indicates no
distant metastasis.
Key Point: N1 specifically refers to limited regional lymph node involvement (1-3 nodes), not
distant metastasis (M category) or tumor depth (T category).
Question 5
A patient is receiving a cell cycle-specific agent that acts during the S-phase. The nurse expects
this drug primarily affects which cellular process?
A. Mitotic spindle formation
B. DNA synthesis and replication
C. RNA transcription
D. Protein synthesis
Correct Answer: B
Rationale: S-phase (synthesis phase) is characterized by DNA replication. Cell cycle-specific
agents acting during S-phase include antimetabolites (e.g., 5-fluorouracil, methotrexate,
cytarabine, gemcitabine) that interfere with DNA synthesis by inhibiting thymidylate synthase,
dihydrofolate reductase, or DNA polymerase. These agents are most effective against rapidly
dividing tumors with high growth fractions.
Key Point: S-phase specific agents target DNA synthesis; M-phase agents (vinca alkaloids,
taxanes) target mitotic spindle formation.
, 4
Question 6
Which statement best describes the process of carcinogenesis?
A. A single mutation in a proto-oncogene immediately causes malignant transformation
B. Multiple genetic and epigenetic alterations accumulate over time, leading to malignant
transformation
C. Carcinogenesis requires simultaneous mutations in all tumor suppressor genes
D. Viral infection is necessary for all types of cancer development
Correct Answer: B
Rationale: Carcinogenesis is a multistep process involving the accumulation of multiple genetic
mutations and epigenetic alterations over time (Vogelstein model of colorectal cancer
progression). This includes activation of oncogenes, inactivation of tumor suppressor genes,
defects in DNA repair mechanisms, and telomerase activation. The "two-hit hypothesis" applies
to tumor suppressor genes, but multiple hits are required across the genome for full malignant
transformation.
Key Point: Cancer develops through clonal evolution with progressive accumulation of genetic
and epigenetic changes, not from single mutations.
Question 7
A tumor is described as "poorly differentiated" in the pathology report. The nurse understands
this indicates:
A. The tumor cells closely resemble normal tissue of origin
B. The tumor cells have lost specialized features and appear immature
C. The tumor has a low mitotic index and slow growth rate
D. The tumor is benign rather than malignant
Correct Answer: B
Rationale: Tumor differentiation describes how closely cancer cells resemble normal tissue
architecture and function. Well-differentiated tumors retain tissue-specific structures and
functions, while poorly differentiated (or undifferentiated/anaplastic) tumors have lost
specialized features, appear immature, and show marked nuclear pleomorphism. Poor
differentiation generally correlates with more aggressive behavior, higher grade, and worse
prognosis, though it does not indicate benign status.
Key Point: Poor differentiation = loss of specialized features and immature appearance; does not
indicate benign status or slow growth.
ONS ONCC CHEMOTHERAPY
IMMUNOTHERAPY CERTIFICATION
Actual Exam 2026/2027 Complete Questions
and Verified Answers Graded A+ Pass
Guaranteed - A+ Graded
DOMAIN 1: FOUNDATIONS OF CANCER & TREATMENT (Questions 1-25)
Subdomain: Cancer Biology (Questions 1-10)
Question 1
A 52-year-old patient is diagnosed with breast cancer. The pathology report indicates the tumor is
estrogen receptor-positive (ER+), HER2-negative, and has a Ki-67 proliferation index of 15%.
The nurse understands that the Ki-67 index measures which cellular process?
A. Rate of apoptosis (programmed cell death)
B. Percentage of cells in the active phases of the cell cycle
C. Degree of tumor differentiation
D. Expression of tumor suppressor genes
Correct Answer: B
Rationale: The Ki-67 protein is present during all active phases of the cell cycle (G1, S, G2, and
mitosis) but absent in resting cells (G0). It serves as a marker of cellular proliferation. A Ki-67
index of 15% indicates that 15% of tumor cells are actively dividing, which helps determine
tumor aggressiveness and guides treatment decisions. Lower Ki-67 indices (<14%) generally
indicate less aggressive tumors with better prognosis, while higher indices (>30%) suggest more
aggressive disease requiring more intensive therapy.
Key Point: Ki-67 is a proliferation marker, not a marker of apoptosis, differentiation, or tumor
suppressor gene expression.
,2
Question 2
A patient asks the nurse to explain why combination chemotherapy is more effective than single-
agent therapy for most cancers. Which response best explains the scientific rationale?
A. "Multiple drugs reduce the likelihood of drug resistance developing"
B. "Combination therapy allows lower doses of each drug, reducing toxicity"
C. "Different drugs target cancer cells at various phases of the cell cycle"
D. "Combining drugs increases the total number of cancer cells killed"
Correct Answer: C
Rationale: The primary rationale for combination chemotherapy is that different agents have
varying mechanisms of action and cell cycle specificity. By combining drugs that target different
phases of the cell cycle (e.g., cell cycle-specific agents like antimetabolites for S-phase and cell
cycle-nonspecific agents like alkylating agents), the regimen can kill cancer cells regardless of
their position in the cell cycle. This approach also reduces the development of resistance (Goldie-
Coldman hypothesis) and allows for dose intensity without exceeding single-agent toxicity
limits.
Key Point: Cell cycle specificity is the fundamental principle underlying combination
chemotherapy regimens.
Question 3
Which genetic alteration is most characteristic of tumor suppressor genes in cancer
development?
A. Gain-of-function mutations that promote continuous cell signaling
B. Loss-of-function mutations that remove cell cycle checkpoints
C. Chromosomal translocations creating fusion proteins
D. Gene amplifications leading to protein overexpression
Correct Answer: B
Rationale: Tumor suppressor genes (e.g., TP53, RB1, BRCA1/2) function as "brakes" on cell
proliferation by regulating cell cycle checkpoints, promoting DNA repair, or inducing apoptosis.
Cancer development typically requires loss-of-function mutations in both alleles (Knudson's
"two-hit hypothesis"), removing these regulatory controls. In contrast, oncogenes involve gain-
of-function mutations, chromosomal translocations (e.g., BCR-ABL in CML), or gene
amplifications (e.g., HER2/neu in breast cancer).
Key Point: Tumor suppressor genes require inactivation (loss-of-function), while oncogenes
require activation (gain-of-function).
,3
Question 4
A patient with colon cancer is staged as T3N1M0 using the TNM system. The nurse understands
that the "N1" designation indicates:
A. Distant metastasis to regional lymph nodes
B. Metastasis to 1-3 regional lymph nodes
C. Tumor invasion through the muscularis propria
D. Presence of lymphovascular invasion
Correct Answer: B
Rationale: In the AJCC TNM staging system for colon cancer, the "N" category describes
regional lymph node involvement: N0 = no regional lymph node metastasis; N1 = metastasis in
1-3 regional lymph nodes (N1a = 1 node, N1b = 2-3 nodes, N1c = tumor deposits without
regional nodal metastasis); N2 = metastasis in 4 or more regional lymph nodes. T3 indicates
tumor invasion through the muscularis propria into pericolorectal tissues, and M0 indicates no
distant metastasis.
Key Point: N1 specifically refers to limited regional lymph node involvement (1-3 nodes), not
distant metastasis (M category) or tumor depth (T category).
Question 5
A patient is receiving a cell cycle-specific agent that acts during the S-phase. The nurse expects
this drug primarily affects which cellular process?
A. Mitotic spindle formation
B. DNA synthesis and replication
C. RNA transcription
D. Protein synthesis
Correct Answer: B
Rationale: S-phase (synthesis phase) is characterized by DNA replication. Cell cycle-specific
agents acting during S-phase include antimetabolites (e.g., 5-fluorouracil, methotrexate,
cytarabine, gemcitabine) that interfere with DNA synthesis by inhibiting thymidylate synthase,
dihydrofolate reductase, or DNA polymerase. These agents are most effective against rapidly
dividing tumors with high growth fractions.
Key Point: S-phase specific agents target DNA synthesis; M-phase agents (vinca alkaloids,
taxanes) target mitotic spindle formation.
, 4
Question 6
Which statement best describes the process of carcinogenesis?
A. A single mutation in a proto-oncogene immediately causes malignant transformation
B. Multiple genetic and epigenetic alterations accumulate over time, leading to malignant
transformation
C. Carcinogenesis requires simultaneous mutations in all tumor suppressor genes
D. Viral infection is necessary for all types of cancer development
Correct Answer: B
Rationale: Carcinogenesis is a multistep process involving the accumulation of multiple genetic
mutations and epigenetic alterations over time (Vogelstein model of colorectal cancer
progression). This includes activation of oncogenes, inactivation of tumor suppressor genes,
defects in DNA repair mechanisms, and telomerase activation. The "two-hit hypothesis" applies
to tumor suppressor genes, but multiple hits are required across the genome for full malignant
transformation.
Key Point: Cancer develops through clonal evolution with progressive accumulation of genetic
and epigenetic changes, not from single mutations.
Question 7
A tumor is described as "poorly differentiated" in the pathology report. The nurse understands
this indicates:
A. The tumor cells closely resemble normal tissue of origin
B. The tumor cells have lost specialized features and appear immature
C. The tumor has a low mitotic index and slow growth rate
D. The tumor is benign rather than malignant
Correct Answer: B
Rationale: Tumor differentiation describes how closely cancer cells resemble normal tissue
architecture and function. Well-differentiated tumors retain tissue-specific structures and
functions, while poorly differentiated (or undifferentiated/anaplastic) tumors have lost
specialized features, appear immature, and show marked nuclear pleomorphism. Poor
differentiation generally correlates with more aggressive behavior, higher grade, and worse
prognosis, though it does not indicate benign status.
Key Point: Poor differentiation = loss of specialized features and immature appearance; does not
indicate benign status or slow growth.
